OptimizeRx Corporation (OPRX) Operating cash flow 2016–2025
OptimizeRx Corporation (OPRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$18.7MFY2025 · since FY2016: -$465,965 → $18.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $18.7M | +282.8% |
| FY2024 | $4.9M | +167.5% |
| FY2023 | -$7.2M | -168.0% |
| FY2022 | $10.7M | +1367.4% |
| FY2021 | $726,039 | +111.5% |
| FY2020 | -$6.3M | -280.0% |
| FY2019 | -$1.7M | -309.5% |
| FY2018 | $792,555 | +153.6% |
| FY2017 | -$1.5M | -217.6% |
| FY2016 | -$465,965 | — |
Source: SEC XBRL filings · For reference only · Not investment advice